CCR2 and myeloid sarcoma: The present study examined expressions of CXCR3, CCR4 and CCR2 on CD4+ T and CD8+ T cells in blood and CSF from relapsing-remitting MS patients and CSF from patients with other inflammatory neurological diseases (INDs).